KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Non-cash Items (2017 - 2023)

Biolife Solutions (BLFS) has disclosed Non-cash Items for 11 consecutive years, with $375355.0 as the latest value for Q1 2023.

  • On a quarterly basis, Non-cash Items fell 24.11% to $375355.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $375355.0, a 24.11% decrease, with the full-year FY2022 number at $7.3 million, down 66.67% from a year prior.
  • Non-cash Items was $375355.0 for Q1 2023 at Biolife Solutions, down from $7.3 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $28.6 million in Q3 2020 to a low of $375355.0 in Q1 2023.
  • A 5-year average of $3.8 million and a median of $727216.5 in 2019 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: plummeted 89.89% in 2019, then soared 1748.94% in 2020.
  • Biolife Solutions' Non-cash Items stood at $737497.0 in 2019, then grew by 12.88% to $832478.0 in 2020, then fell by 24.98% to $624531.0 in 2021, then skyrocketed by 1068.88% to $7.3 million in 2022, then plummeted by 94.86% to $375355.0 in 2023.
  • Per Business Quant, the three most recent readings for BLFS's Non-cash Items are $375355.0 (Q1 2023), $7.3 million (Q4 2022), and $9.4 million (Q3 2022).